Adele Boccuto
Overview
Explore the profile of Adele Boccuto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
265
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-Lozano M, Dragoni F, Gallego P, Mazzotta S, Lopez-Gomez A, Boccuto A, et al.
Bioorg Chem
. 2023 Feb;
133:106408.
PMID: 36801791
Since 2011 Direct Acting antivirals (DAAs) drugs targeting different non-structural (NS) viral proteins (NS3, NS5A or NS5B inhibitors) have been approved for clinical use in HCV therapies. However, currently there...
2.
Marchi S, Dragoni F, Boccuto A, Idoko O, Zazzi M, Sow S, et al.
Acta Trop
. 2022 Nov;
237:106736.
PMID: 36374844
Genetic and phylogenetic studies indicated that Zika virus (ZIKV) has evolved into 2 major lineages, the African and Asian. However, ZIKV has been described as a single serotype. This study...
3.
Luongo F, Dragoni F, Boccuto A, Paccagnini E, Gentile M, Canosi T, et al.
Cells
. 2022 May;
11(9).
PMID: 35563737
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may affect female reproductive health. Here, we investigated the potential of SARS-CoV-2 to infect the follicular microenvironment, in particular granulosa (GCs) and cumulus...
4.
Cirri D, Marzo T, Tolbatov I, Marrone A, Saladini F, Vicenti I, et al.
Biomolecules
. 2021 Dec;
11(12).
PMID: 34944502
Metal-based drugs represent a rich source of chemical substances of potential interest for the treatment of COVID-19. To this end, we have developed a small but representative panel of nine...
5.
Gherardini L, Inzalaco G, Imperatore F, DAurizio R, Franci L, Miragliotta V, et al.
Cancers (Basel)
. 2021 Oct;
13(19).
PMID: 34638314
Inhibition of DDX3X expression or activity reduces proliferation in cells from various tumor tissues, in particular in breast cancer, and its expression often correlates to tumor aggressiveness. This makes DDX3X...
6.
Vicenti I, Gatti F, Scaggiante R, Boccuto A, Zago D, Basso M, et al.
Life (Basel)
. 2021 Sep;
11(9).
PMID: 34575045
We aimed to investigate neutralizing antibody titers (NtAbT) to the P.1 and B.1 SARS-CoV-2 variants in a cohort of healthy health care workers (HCW), including 20 previously infected individuals tested...
7.
Vicenti I, Basso M, Gatti F, Scaggiante R, Boccuto A, Zago D, et al.
Int J Infect Dis
. 2021 Sep;
112:40-44.
PMID: 34481967
Objectives: This study aimed to describe the longitudinal evolution of neutralizing antibody titres (NtAb) in three different cohorts of healthcare workers (HCWs), including vaccinated HCWs with and without a previous...
8.
Saladini F, Giannini A, Giammarino F, Boccuto A, Dragoni F, Vicenti I, et al.
J Antimicrob Chemother
. 2021 Aug;
76(12):3310-3312.
PMID: 34402509
No abstract available.
9.
Martina M, Vicenti I, Bauer L, Crespan E, Rango E, Boccuto A, et al.
ChemMedChem
. 2021 Aug;
16(23):3548-3552.
PMID: 34382337
Over half a century since the description of the first antiviral drug, "old" re-emerging viruses and "new" emerging viruses still represent a serious threat to global health. Their high mutation...
10.
Boccuto A, Dragoni F, Bergna A, Della Ventura C, Giammarino F, Saladini F, et al.
J Infect
. 2021 Aug;
84(1):94-118.
PMID: 34371077
No abstract available.